Cadmium inhibits mismatch repair by blocking the ATPase activity of the MSH2-MSH6 complex

Area of Science:

• Molecular Biology
• Environmental Toxicology
• Cancer Research

Background:

• Cadmium (Cd2+) is a known carcinogen.
• Cadmium exposure is linked to DNA damage and cancer.
• The DNA mismatch repair (MMR) pathway corrects errors during DNA replication.

Purpose of the Study:

• To investigate the effect of Cadmium (Cd2+) on the enzymatic activity of the MSH2-MSH6 mismatch binding complex.
• To elucidate the mechanism by which Cadmium (Cd2+) inhibits DNA mismatch repair.

Main Methods:

• In vitro enzymatic assays measuring ATP binding, hydrolysis, and DNA mismatch binding of MSH2-MSH6.
• Dose- and time-dependent inhibition studies.
• Comparative inhibition studies with N-ethyl maleimide.
• Yeast cell-based assays to assess mutator phenotypes.

Main Results:

• Cadmium (Cd2+) strongly inhibits the ATPase activity of MSH2-MSH6.
• Cadmium (Cd2+) has a weaker inhibitory effect on DNA mismatch binding.
• Inhibition is dose- and time-dependent and involves targeting cysteine and histidine residues.
• Zinc (Zn2+) prevents Cadmium (Cd2+)-induced mutator phenotypes in yeast by blocking Cadmium entry.

Conclusions:

• Cadmium (Cd2+) inhibits DNA mismatch repair by inactivating the ATPase activity of the MSH2-MSH6 heterodimer.
• This inactivation leads to a dominant negative effect and a mutator phenotype.
• Understanding Cadmium's mechanism of MMR inhibition is crucial for cancer prevention and treatment strategies.